Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Capsulaser
AddedFeb 17, 2024
UpdatedJun 18, 2026
Capsulaser

Capsulaser

Seed

Capsulaser: Efficient laser tech for tear-resistant capsulotomy in cataract surgery, founded in 2016.

HQ
Livermore, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Capsulaser, founded in 2016 in Livermore, CA, specializes in laser technology for cataract surgery. The company focuses on creating tear-resistant capsulotomies, offering a cost and time-effective solution for surgeons. Unlike traditional methods that use a pulsed beam, Capsulaser's technology delivers laser energy continuously, reducing the risk of tissue bridges and enhancing surgical precision.

Capsulaser has made significant strides in the ophthalmic field, with notable contributions from experts like Pavel Stodulka MD, PhD, and Richard Packard MD. Their innovative approach has been showcased at prominent symposiums such as ASCRS JCRS. The company's advancements have improved surgical outcomes, positioning Capsulaser as a key player in enhancing cataract surgery techniques.

Capsulaser - Similar Companies

ViaLase logo

ViaLase

vialase.com

Full Spectrum Laser logo

Full Spectrum Laser

fslaser.com

Proto Lase logo

Proto Lase

protolase.com

6 D Laser logo

6 D Laser

6dlaser.com

CapsoVision logo

CapsoVision

capsovision.com

Encapsule Medical logo

Encapsule Medical

encapsule.com

Ace Vision Group logo

Ace Vision Group

acevisiongroup.com

ClearCam logo

ClearCam

clearcam-med.com

Precise Light Surgical logo

Precise Light Surgical

Cutera logo

Cutera

cutera.com

Resonetics logo

Resonetics

Capstan Medical logo

Capstan Medical

capstanmedical.com

Skarp Technologies logo

Skarp Technologies

Biolase logo

Biolase

biolase.com

Endurance Lasers logo

Endurance Lasers

Capsulaser - Quick Facts

Who are Capsulaser's competitors?

Companies similar to Capsulaser include ViaLase, Full Spectrum Laser, Proto Lase and 6 D Laser.

When was Capsulaser founded?

Capsulaser was founded in 2016.

Where is Capsulaser's headquarters located?

Capsulaser's headquarters is located in Livermore, CA, US.

When was Capsulaser's last funding round?

Capsulaser's most recent funding round was for $4.5M (USD) in July 2021.

How much has Capsulaser raised to-date?

As of Jul 15, 2021, Capsulaser has raised a total of $4.5M (USD).

How many employees does Capsulaser have?

Capsulaser has 5 employees as of Feb 4, 2024.

Capsulaser - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Laser Technology
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified